FIELD: pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, namely to a liquid pharmaceutical composition having anti-inflammatory, antiseptic and analgesic action for treating diseases of the oral cavity and ENT organs. A liquid pharmaceutical composition having anti-inflammatory, antiseptic and analgesic action for treating diseases of the oral cavity and ENT organs, containing benzydamine hydrochloride, octenidine hydrochloride, phenoxyethanol and auxiliary substances in the following ratio of components, wt.%: octenidine hydrochloride – 0.1; phenoxyethanol – 0.5; benzydamine hydrochloride – 0.15; cocamidopropyl betaine – 0.2-0.5; glycerol – 2.5-7.0; sodium D-gluconate – 0.3-0.7; water for injections – up to 100.
EFFECT: above described composition has pronounced anti-inflammatory, antiseptic and analgesic action, is effective for treating diseases of the oral cavity and ENT organs, without negative effects, is characterized by improved organoleptic properties.
4 cl, 8 dwg, 9 tbl, 6 ex
Authors
Dates
2025-03-31—Published
2024-03-22—Filed